This information was published on 2023-05-17T10:08:24 for IP Right Registration Published.
| Field | Value |
| (210) | 2236765 (IR 1632847) |
| (220) |
13 Oct 2021
|
| (300) |
CH, 25 Jun 2021, 770721
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Pharmaceutical products; pharmaceutical drugs; medicinal preparations and substances; all aforementioned goods excluding herbicides; herbicides for agricultural use; fungicides; fungicides for agricultural use; fungicides for horticultural use; turf fungicides; biological insecticides; chemicals for forestry (insecticides); insecticides; parasiticides; weedkillers; therapeutic preparations for the cardiovascular system; pharmaceutical and medicinal preparations and substances for the treatment of diabetes; pharmaceutical and medicinal preparations and substances for use in oncology; pharmaceutical and medicinal preparations, substances and compositions for the treatment and/or prevention of cancer; pharmaceutical and medicinal preparations and substances for the treatment of neurodegenerative disorders; pharmaceutical and medicinal preparations and substances for the treatment of metabolic disorders; pharmaceutical and medicinal preparations and substances for the treatment of musculoskeletal disorders; pharmaceutical and medicinal preparations and substances for the treatment of osteoarthritis; pharmaceutical and medicinal preparations and substances for the treatment of genetic disorders and rare diseases. Class 42 Scientific research; pharmaceutical research; medicinal research; technical advice and product development for third parties in the field of pharmacy; research and development of pharmaceuticals and medicinal preparations and substances for third parties; research and development of pharmaceuticals and medicinal preparations and substances for the treatment of cancer; research and development of pharmaceuticals and medicinal preparations and substances for treating inflammation; research and development of pharmaceuticals and medicinal preparations and substances for the treatment of neurodegenerative disorders; research and development of pharmaceutical and medicinal preparations and substances for the treatment of metabolic disorders; research and development of pharmaceutical and medicinal preparations and substances for the treatment of musculoskeletal disorders; research and development of pharmaceutical and medicinal preparations and substances for the treatment of osteoarthritis; research and development of pharmaceutical and medicinal preparations and substances for the treatment of genetic disorders and rare diseases. |
| (540) | Floratek |
| (550) | Word |
| (730) |
Floratek Pharma SA
|
| (750) |
Chrysiliou IP
|
Find out more about publications on the About page.